StockNews.AI
TMDX
StockNews.AI
143 days

TMDX Investors Have Opportunity to Lead the TransMedics Securities Fraud Lawsuit with Faruqi & Faruqi, LLP

1. Faruqi & Faruqi investigates claims against TMDX for investor losses. 2. Deadline for lead plaintiff in securities class action is April 15, 2025.

2m saved
Insight
Article

FAQ

Why Very Bearish?

Legal actions negatively impact stock prices, as seen with recent cases against similar companies.

How important is it?

Investor lawsuits can lead to decreased confidence and stock selling, significantly impacting TMDX.

Why Short Term?

Legal actions can quickly affect investor sentiment and stock prices, often leading to declines.

Related Companies

AXNXISRGALGN
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In TransMedics To Contact Him Directly To Discuss Their Options NEW YORK CITY, NY / ACCESS Newswire / March 29, 2025 / If you suffered losses exceeding $50,000 in TransMedics between February 23, 2023 and January 10, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against TransMedics Group, Inc. ("TransMedics" or the "Company") (NASDAQ:TMDX) and reminds investors of the April 15, 2025deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Related News